Gerd Sutter
- Virology top 0.1%
- Poxvirus research and outbreaks 71
- HIV Research and Treatment 25
- Immunology top 0.2%
- Immunotherapy and Immune Responses 48
- Immune Cell Function and Interaction 23
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research 21
- Epidemiology top 0.5%
- Herpesvirus Infections and Treatments 53
- Animal Science and Zoology top 0.5%
- Animal Virus Infections Studies 27
-
- Virus-based gene therapy research 64
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Gerd Sutter
205 papers receiving 9.7k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Virology 3.7k
- Immunology 4.4k
- Infectious Diseases 2.4k
- Epidemiology 3.9k
- Animal Science and Zoology 905
Countries citing papers authored by Gerd Sutter
This map shows the geographic impact of Gerd Sutter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerd Sutter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerd Sutter more than expected).
Fields of papers citing papers by Gerd Sutter
This network shows the impact of papers produced by Gerd Sutter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerd Sutter. The network helps show where Gerd Sutter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gerd Sutter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 5 | |
| 11 | 2021 | 9 | |
| 12 | 2021 | 9 | |
| 13 | 2020 | 58 | |
| 14 | 2020 | 12 | |
| 15 | 2020 | 6 | |
| 16 | 2019 | 8 | |
| 17 | 2019 | 13 | |
| 18 | 2018 | 30 | |
| 19 | 2017 | 10 | |
| 20 | 2002 | 128 |
About Gerd Sutter
Gerd Sutter is a scholar working on Virology, Immunology and Infectious Diseases, having authored 211 papers that have together received 10.0k indexed citations. Recurring topics across this work include Poxvirus research and outbreaks (71 papers), Virus-based gene therapy research (64 papers), Herpesvirus Infections and Treatments (53 papers), Immunotherapy and Immune Responses (48 papers), Animal Virus Infections Studies (27 papers), HIV Research and Treatment (25 papers), Immune Cell Function and Interaction (23 papers) and SARS-CoV-2 and COVID-19 Research (21 papers). The work is most often cited by research in Virology (3.7k citations), Immunology (4.4k citations) and Infectious Diseases (2.4k citations). Gerd Sutter has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Bernard Moss, Caroline Staib, Volker Erfle, Ingo Drexler, Asisa Volz, H. Meyer, A. Mayr, Holger Ludwig, Robert Fux and Yasemin Suezer. Their work appears in journals such as Journal of Virology, Vaccine, Journal of General Virology, Viruses and Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.